Software Alternatives, Accelerators & Startups
Register | Login

Protocol Deviation VS Portfolio Backtest

Compare Protocol Deviation VS Portfolio Backtest and see what are their differences

ZeroTwo AI
ZeroTwo is a premium multi-provider AI platform which combines the tools models and features of Claude, Gemini, Grok, Openai and more into one. Canvas, Deep Research, MCP, Connectors, Agents, Projects and even Apps are all available in one place! sponsored
Note: These products don't have any matching categories. If you think this is a mistake, please edit the details of one of the products and suggest appropriate categories.
Contents:
  1. » Base Details
  2. » Videos
  3. » Reviews
  4. » Alternatives

Protocol Deviation logo Protocol Deviation

eClinical platform for clinical trials

Portfolio Backtest logo Portfolio Backtest

Create portfolio backtests quickly and easily by describing them in plain English. Our AI will find the relevant Stocks or ETFs and create the backtest for you.
  • Protocol Deviation Landing page
    Landing page //
    2022-11-18
  • Portfolio Backtest Write you backtest in natural language
    Write you backtest in natural language //
    2025-06-04
  • Portfolio Backtest Return Summary
    Return Summary //
    2025-06-04
  • Portfolio Backtest Portfolio Value
    Portfolio Value //
    2025-06-04
  • Portfolio Backtest Portfolio Drawdowns
    Portfolio Drawdowns //
    2025-06-04
  • Portfolio Backtest Annual Returns
    Annual Returns //
    2025-06-04

I built Portfolio Backtest because I wanted an easy way to backtest hypothetical portfolios.

Alternatives required you to fill out long complicated forms to construct the backtest but I wanted something where you could just describe what you wanted in plain english.

Once created I wanted it to be able to track CAGR, portfolio value over, returns by year, drawdowns and a range of other metrics.

Protocol Deviation

Website
protocoldeviation.com
$ Details
-
Release Date
-
Edit details

Portfolio Backtest

Website
portfoliobacktest.com
$ Details
freemium
Release Date
2025 June
Startup details
Country
Australia
State
NSW
City
Mortdale
Founder(s)
Rhys Diab
Employees
1 - 9
Edit details

Protocol Deviation features and specs

No features have been listed yet.

Portfolio Backtest features and specs

  • Easy Portfolio Backtesting
    Portfolio Backtest provides a straightforward interface for testing historical performance of investment portfolios, making it accessible to both beginner and intermediate investors who want to evaluate asset allocation strategies.
  • Multiple Asset Support
    The platform supports backtesting across a variety of asset classes including stocks, ETFs, and mutual funds, allowing users to construct diversified portfolios and analyze their historical behavior.
  • Visual Performance Charts
    The tool provides clear visual charts and graphs showing portfolio growth, drawdowns, and other performance metrics over time, making it easy to compare different allocation strategies at a glance.
  • Free to Use
    Portfolio Backtest offers free access to its core backtesting features, which lowers the barrier to entry for individual investors who want to test strategies without committing to expensive subscription-based tools.
  • Portfolio Comparison
    Users can compare multiple portfolio configurations side by side, enabling them to evaluate the impact of different asset allocations and rebalancing strategies on risk-adjusted returns.

Possible disadvantages of Portfolio Backtest

  • Limited Historical Data
    The platform may have limited historical data depth compared to more premium backtesting tools, which can restrict the ability to test strategies over very long time horizons or during specific market events.
  • Basic Analytics
    Compared to professional-grade tools like Portfolio Visualizer or QuantConnect, the analytics and risk metrics available on Portfolio Backtest can be relatively basic, lacking advanced measures such as factor exposure analysis or Monte Carlo simulations.
  • Limited Customization Options
    The tool may not offer extensive customization for rebalancing frequencies, tax-loss harvesting simulations, or custom benchmarks, which limits its usefulness for more sophisticated portfolio strategies.
  • Smaller User Community
    Portfolio Backtest has a smaller user base and community compared to more established platforms, meaning there are fewer tutorials, forums, and shared strategies available for new users seeking guidance.
  • Survivorship Bias Risk
    Like many free backtesting tools, Portfolio Backtest may be subject to survivorship bias in its asset database, as delisted or failed securities might not be included, potentially leading to overly optimistic backtest results.

Analysis of Protocol Deviation

Overall verdict

  • Protocol Deviation appears to be a niche resource focused on clinical trial and research compliance topics, which can be valuable for those in the industry, though independent verification of its authority, accuracy, and update frequency is recommended before relying on it for critical decisions.

Why this product is good

  • Focuses on a specialized topic (protocol deviations in clinical research) that is often underserved by general resources
  • May offer practical guidance for handling deviations, documentation, and regulatory compliance
  • Can serve as a convenient reference point for clinical research professionals seeking quick information

Recommended for

  • Clinical research coordinators and associates managing trial compliance
  • Regulatory affairs and quality assurance professionals in life sciences
  • Sponsors, CROs, and site staff needing guidance on documenting and reporting protocol deviations
  • Students or newcomers learning about Good Clinical Practice (GCP) and trial management

Analysis of Portfolio Backtest

Overall verdict

  • Portfolio Backtest is a solid tool for investors who want to validate investment strategies using historical data before committing real capital, offering a practical way to assess risk and returns.

Why this product is good

  • Allows users to test investment strategies against historical market data to evaluate potential performance
  • Helps identify risk exposure and drawdown potential before investing real money
  • Provides data-driven insights that can improve decision-making and reduce emotional investing
  • Often includes portfolio comparison features to benchmark strategies against indices or other allocations
  • Accessible interface that doesn't require advanced coding or statistical expertise

Recommended for

  • DIY retail investors testing asset allocation strategies
  • Financial planners validating client portfolio recommendations
  • Quantitative hobbyists experimenting with factor-based or rules-based strategies
  • Long-term investors wanting to stress-test portfolios against historical downturns
  • Users comparing passive vs active investment approaches before committing funds

Protocol Deviation videos

+ Add

Protocol Deviations

More videos:

  • Review - What Is A Protocol Deviation?
  • Review - The Differences Between Protocol Deviations and Violations In Clinical Research Both Minor and Major

Portfolio Backtest videos

+ Add

Create Portfolio Backtest With Plain Language

Category Popularity

0-100% (relative to Protocol Deviation and Portfolio Backtest)

Protocol Deviation

Portfolio Backtest

Clinical Trial Management System
100 100%
Clinical Trial Management System
0% 0
Finance
0 0%
Finance
100% 100
Healthcare
100 100%
Healthcare
0% 0
Investing
0 0%
Investing
100% 100

User comments

Share your experience with using Protocol Deviation and Portfolio Backtest. For example, how are they different and which one is better?
Log in or Post with

What are some alternatives?

When comparing Protocol Deviation and Portfolio Backtest, you can also consider the following products

Loading...